155 related articles for article (PubMed ID: 31913907)
21. Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy.
Liu J; Hui C; Ladbury C; Waddington T; Erhunmwunsee L; Raz D; Kim J; Salgia R; Chenery S; Pearlstein D; Schwer A; Amini A
Clin Lung Cancer; 2021 Sep; 22(5):e678-e683. PubMed ID: 33712362
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
Ma SJ; Serra LM; Syed YA; Hermann GM; Gomez-Suescun JA; Singh AK
Clin Lung Cancer; 2018 Mar; 19(2):e235-e240. PubMed ID: 29153897
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
[TBL] [Abstract][Full Text] [Related]
24. Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
Fischer-Valuck BW; Boggs H; Katz S; Durci M; Acharya S; Rosen LR
Tumori; 2015; 101(3):287-93. PubMed ID: 25908031
[TBL] [Abstract][Full Text] [Related]
25. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
[TBL] [Abstract][Full Text] [Related]
26. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.
Samson P; Rehman S; Juloori A; DeWees T; Roach M; Bradley J; Videtic GMM; Stephans K; Robinson C
Pract Radiat Oncol; 2018; 8(6):404-413. PubMed ID: 29907514
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
Crabtree TD; Denlinger CE; Meyers BF; El Naqa I; Zoole J; Krupnick AS; Kreisel D; Patterson GA; Bradley JD
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):377-86. PubMed ID: 20400121
[TBL] [Abstract][Full Text] [Related]
29. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
J Thorac Oncol; 2016 Aug; 11(8):1319-1325. PubMed ID: 27234604
[TBL] [Abstract][Full Text] [Related]
31. Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Ye L; Shi S; Zeng Z; Huang Y; Hu Y; He J
Jpn J Clin Oncol; 2018 Feb; 48(2):160-166. PubMed ID: 29253245
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
Cassidy RJ; Patel PR; Zhang X; Press RH; Switchenko JM; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Sep; 18(5):551-558.e6. PubMed ID: 28373068
[TBL] [Abstract][Full Text] [Related]
33. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer.
Mak RH; Hermann G; Lewis JH; Aerts HJ; Baldini EH; Chen AB; Colson YL; Hacker FH; Kozono D; Wee JO; Chen YH; Catalano PJ; Wong KK; Sher DJ
Clin Lung Cancer; 2015 Jan; 16(1):24-32. PubMed ID: 25450872
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
35. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
37. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.
Mancini BR; Park HS; Harder EM; Rutter CE; Corso CD; Decker RH; Husain ZA
Lung Cancer; 2016 Jul; 97():22-7. PubMed ID: 27237023
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
[TBL] [Abstract][Full Text] [Related]
39. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
Sittenfeld SMC; Juloori A; Reddy CA; Stephans KL; Videtic GMM
Clin Lung Cancer; 2021 May; 22(3):e360-e365. PubMed ID: 32624412
[TBL] [Abstract][Full Text] [Related]
40. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
